Pneumonia is the leading cause of infection-related death and represents the fifth cause of mortality in the elderly. There are several reported risk factors for acquiring pneumonia at an older age, such as alcoholism, lung and heart diseases, nursing home residence, and swallowing disorders. Hospital-acquired pneumonia (HAP) is reviewed, with an emphasis on multidrug-resistant (MDR) bacterial pathogens, such as Pseudomonas aeruginosa, Acinetobacter species, and methicillin-resistant Staphylococcus aureus. The clinical characteristics of pneumonia in the elderly differ substantially compared with younger patients, and the severity of the disease is strongly associated with increased age and age-related comorbid disorders. Streptococcus pneumoniae is the pathogen most frequently responsible for pneumonia in the elderly with early HAP without risk factors for MDR; enteric Gramnegative rods should be considered in nursing home-associated pneumonia, as well as anaerobes in patients with aspiration pneumonia. Special attention should be given to preventive measures such as vaccination, oral care, and nutrition. The management of HAP should be instituted early with: appropriate use of antibiotics in adequate doses; avoidance of excessive use of antibiotics by de-escalation of initial antibiotic therapy, based on microbiologic cultures and the clinical response of the patient; and reduction of the duration of treatment to the minimum effective period.
Introduction
Hospital-acquired pneumonia (HAP) is a respiratory infection which occurs 48 hours after hospital admission. It is an important cause of hospital morbidity, observed most frequently in medical wards and in elderly patients with severe underlying illnesses. HAP is the second most frequent cause of nosocomial infection, accounting for 15-20% of such infections 1 . It occurs in 0.5-1.5% of inpatients and is usually caused by bacteria.
HAP accounts for more than 50% of all antibiotics prescribed 2 . It is currently the most common infection contributing to high mortality and morbidity 3 . HAP is the leading cause of death among hospital-acquired infections, with the crude mortality rate for HAP perhaps as high as 20-71%, but many of the patients with HAP die of their underlying disease rather than pneumonia 4 . An increase in mortality attributable to HAP is related to the presence of multidrug-resistant (MDR) pathogens. The clinical characteristics of pneumonia in the elderly differ substantially from those in younger patients, and the severity of the disease is, therefore, strongly associated with increased age and age-related comorbidities 5 . Moreover, the length of hospital stay and the mortality rate are significantly higher in the elderly 6 . The time of onset of pneumonia and risk factors for specific patients with HAP are variable. The microbial etiology of pneumonia may also vary with age and care setting, resulting in the need to adequately amend the antibiotic choice in the elderly. Aspiration pneumonia is also an important clinical feature in elderly patients suffering from cerebrovascular disorderassociated dysphagia 7 .
Risk Factors and Prognosis
The parameters associated with an increased risk of pneumonia include alcoholism, swallowing disorders, male gender, age greater than 60 years, neoplasms, chronic obstructive pulmonary disease (COPD), diabetes, heart failure, immunosuppression, intubation, and prolonged ventilation [8] [9] [10] [11] . Low serum albumin is also one of the predictors for pneumonia developing in the elderly, and malnutrition is more often found in elderly patients with pneumonia 11 .
There are different risk factors for HAP with varied pathogens. Risk factors for infection with Streptococcus pneumoniae include > 65 years, β-lactam therapy within the previous 3 months, alcoholism, cirrhosis, chronic cardiovascular or pulmonary disease, diabetes mellitus, corticosteroid use, multiple comorbidities, functional or anatomic asplenia, cerebrospinal fluid leak, and immunosuppressive disorder or treatment 12 . Risk factors for enteric Gram-negative rods include nursing home residence, cardiopulmonary disease, multiple comorbidities, and recent antibiotic therapy. Infection by Pseudomonas aeruginosa is associated with a number of risk factors that are not associated with age but with structural lung diseases, recent antibiotic treatment, broad spectrum antibiotic use for more than 7 days in the last month, malnutrition, and prednisone > 10 mg/ day. Risk factors for infection with Staphylococcus aureus include end-stage renal disease, injection drug abuse, prior influenza, and prior antibiotic use (particularly fluoroquinolones), diabetes mellitus, head trauma, and intubation 10, 13 . Conditions known to increase mortality include prolonged mechanical ventilatory support, an underlying fatal condition, age greater than 60 years, bilateral radiographic infiltrates, prior antibiotic therapy, prior pneumonia with superinfection, chronic lung disease, low body mass index, Gram-negative bacilli, polymicrobial flora, and microbes that have acquired antibiotic resistance [14] [15] [16] . Increased mortality rates were also associated with bacteremia, especially with P. aeruginosa or Acinetobacter species, medical rather than surgical disease, and therapy with ineffective antibiotic treatment 15, 17 .
Etiology HAP may be caused by a wide spectrum of bacterial pathogens, and is more frequently polymicrobial in ventilator-associated pneumonia 18 . HAP is rarely caused by viral or fungal pathogens in immunocompetent patients 8, 19 . It has been established that colonization dramatically increases in patients with acidosis, alcoholism, azotemia, coma, diabetes mellitus, hypotension, leukocytosis, leukopenia, pulmonary disease, endotracheal or nasogastric intubation, and in patients given antimicrobial agents 20, 21 . With gastric pH > 4, microorganisms are able to increase to high concentrations in the stomach 22 . This can happen in patients with advanced age, achlorhydria, ileus, upper gastrointestinal disease, enteral feeding, antacids, and histamine 2 (H 2 ) antagonists 22, 23 . Impaired intestinal motility is also attributed to gastric colonization in patients 24 . In addition, certain conditions such as malnutrition, severe illness or post-operative state can increase the adherence of Gram-negative bacteria 25 . There are a number of factors that enhance colonization of the oropharynx and/or stomach by microbes, including administration of antimicrobial agents, presence of underlying chronic lung disease, prolonged mechanical ventilatory support, contact with contaminated or colonized hands, extreme old age, malnutrition, severe underlying conditions, and immunosuppression 26, 27 . The high incidence of Gram-negative bacillary pneumonia in hospitalized patients appears to be the result of factors that promote colonization of the pharynx by Gram-negative bacilli and the subsequent entry of these microorganisms into the lower respiratory tract 21 .
Early-onset HAP occurs within the first 4 days of hospitalization and usually has a better prognosis. Earlyonset HAP without risk factors for MDR is often caused by typical antimicrobial-susceptible organisms such as S. pneumoniae, Haemophilus influenzae, methicillinsensitive S. aureus, and antibiotic-sensitive enteric Gramnegative bacilli (Escherichia coli, Klebsiella pneumoniae, Enterobacter species, Proteus species, and Serratia marcescens) 28 . Several studies have demonstrated that pneumonia caused by Mycoplasma pneumoniae is less common in elderly patients 29 , and viruses, mainly influenza and the respiratory syncytial virus, also play a role in the occurrence of pneumonia in the elderly 30 .
Silent aspiration during sleep seems to happen more frequently in elderly people with pneumonia, regardless of neurologic disorders 31 . Aspiration of nasopharyngeal 19, 33 . An acute cerebrovascular disorder seems to be the most common cause of swallowing difficulties. Up to 80% of these patients present with dysphagia, and 40-50% develop aspiration pneumonia 32 . It has been reported that the oral hygiene in the elderly is frequently poor, facilitating the development of abundant oral flora that can induce further airway colonization and infection 34 . Furthermore, the elderly tend to develop poor functional status and feeding problems, which further increases the risk of aspiration pneumonia 35 . The diagnosis of pneumonia in elderly persons with cerebrovascular disease and swallowing difficulties should take into account possible aspiration and provide for wide antimicrobial coverage, including anaerobes and enteric Gram-negative bacteria. HAP involving anaerobic organisms may follow aspiration in non-intubated patients, but is rare in intubated patients 36 .
The most common pathogens of late HAP are P. aeruginosa, S. aureus, Enterobacteriaceae (especially Klebsiella, E. coli and Enterobacter species), and methicillin-resistant S. aureus (MRSA) 8, 37 . The longer a patient is in hospital, the wider the spectrum of likely pathogens and the more likely they are to be MDR. Late-onset HAP (5 days or more) is more likely to be caused by MDR organisms, and is associated with increased mortality and morbidity. The risk factors of MDR pathogens include being hospitalized in an acute care hospital for 2 days or more in the preceding 90 days, prior antibiotic use especially broad-spectrum drugs (a third-generation cephalosporin, a fluoroquinolone, and/or a carbapenem), being resident in a nursing home or extended care facility, having received recent intravenous antibiotic therapy, chronic dialysis within the past 30 days, home wound care within the past 30 days, current hospitalization of 5 days or more, a family member with MDR, and immunosuppression 4, 38 . The bacteriology of HAP in non-ventilated patients is similar to that in ventilated patients, including aerobic Gram-negative bacilli, P. aeruginosa, K. pneumoniae, Acinetobacter species, as well as Gram-positive cocci, such as S. aureus, much of which is MRSA; anaerobes are an uncommon cause of ventilator-associated pneumonia 8, 36 . Some microbes, such as MRSA and K. pneumonia, are more common in non-ventilated than ventilated patients, whereas certain resistant Gramnegative bacilli are more common in patients with ventilator-associated pneumonia (P. aeruginosa, Stenotrophomonas maltophilia, and Acinetobacter species). In one study of 52 patients aged 70 years who failed to respond to 72 hours of antibiotics, MRSA (33%), Gramnegative enterics (24%) and Pseudomonas species (14%) were the most frequent pathogens isolated by bronchoscopy. It was noted that 72% had at least two comorbidities, whereas 23% had three or more 39 . The frequency of specific MDR pathogens causing HAP may vary by hospital, patient population, exposure to antibiotics, type of intensive care unit patient and changes over time, addressing the need for timely, local surveillance data 8, 15, 37, 40 .
Environmental microorganisms such as Legionella species and Aspergillus species should be considered in HAP in patients not receiving ventilation. Legionella pneumophila is increased in immunocompromised hosts, such as organ transplant recipients, human immunodeficiency virus disease, diabetes mellitus, underlying lung disease, and end-stage renal disease 41 . HAP due to Legionella species is more common in hospitals where the pathogen is present in the hospital water supply. Detection is based on the widespread use of Legionella urinary antigen. Disease due to serogroups other than serogroup 1 may be underdiagnosed. Controlling the risk of Legionella in hospital water supplies decreases the risk of Legionella pneumonia.
Evaluation and Diagnosis
It is difficult to diagnose HAP. Traditional criteria, such as fever, cough, sputum production and pleuritic chest pain, are not sufficiently accurate to confirm pneumonia. The clinical presentation of pneumonia in older patients is often without the typical acute symptoms observed in young adults 42 . This clinical paucity causes a delay of diagnosis by ≥ 72 hours, contributing to further mortality. However, altered mental status (delirium) may be a common manifestation of pneumonia in older patients 43 . Both clinical features and physical findings may be lacking or misrepresented in elderly patients. All patients should be screened by pulse oximetry, which may imply the presence of pneumonia in patients without obvious signs of pneumonia 44 .
In addition, elderly patients with pneumonia are more likely to have an unclear pulmonary infiltrate on chest radiography 45 . For patients with suspected pneumonia but who have negative chest radiography findings, it may be reasonable to treat their condition presumptively with antibiotics and repeat the imaging in 24-48 hours. Chest tomographies may be more sensitive 46 . The presence of a new or progressive radiographic infiltrate with at least two of three clinical features, fever greater than 38°C, leukocytosis or leukopenia, and purulent secretions, represent the most accurate clinical criteria for beginning empirical antibiotic therapy 47 . Direct staining is a simple procedure, providing valuable information within 1 hour. A reliable Gram stain can be used to guide initial antibiotic therapy and may increase the diagnostic value of the clinical pulmonary infection score (CPIS) 48, 49 . Reevaluation of the decision to use antibiotics according to the results of semiquantitative lower respiratory tract cultures and serial clinical evaluations is necessary by day 3 or sooner 50 . A CPIS of 6 or less for 3 days is an objective criterion to select patients at low risk for early discontinuation of empirical therapy for HAP 51 .
The application of noninvasive diagnostic tests did not allow us to determine the importance of microorganisms that are normal oropharyngeal flora or which colonize hospitalized patients. The etiologic diagnosis was only established in one-third of the cases of HAP in noncritical patients because of the inability to perform invasive procedures in most of the patients 52 .
If bronchoscopic sampling is not immediately available, non-bronchoscopic sampling can reliably get lower respiratory tract secretions for quantitative cultures, which can be used to guide antibiotic therapy 53 . Invasive sampling methods involve bronchoscopic techniques to obtain quantitative cultures of protected specimen brush and bronchoalveolar lavage. The reported sensitivities and specificities of these methods range from 70-100% and 60-100%, respectively, depending on the tests or diagnostic criteria with which they are compared 54, 55 . A major factor causing false-negative quantitative cultures is the recent initiation of, or change in, antimicrobial therapy, especially in the prior 24 hours, but up to 72 hours 56, 57 . The threshold of quantitative cultures of protected specimen brush is 10 3 colony-forming unit/mL or more. The threshold of bronchoalveolar lavage is 10 4 or 10 5 colony-forming unit/mL, and the advantage of looking for intracellular organisms is the ability to obtain data of high predictive value in a rapid time frame. The diagnostic threshold may be lowered if the patient has had changes in antibiotic therapy recently or if the probability of infection is high. Soluble triggering receptor expressed on myeloid cells coupled with the classic clinical criteria and results of microbiologic cultures may be a valuable tool with which to enhance the specificity and maintain the sensitivity of HAP diagnosis 58 . Delays in the initiation of appropriate antibiotic therapy can increase the mortality and, therefore, therapy should not be postponed for the purpose of performing diagnostic studies in patients who are clinically unstable 59 . Clinically unstable patients with signs of infection should receive therapy, in spite of initial bronchoscopic findings 56 . The use of lung tissue for diagnosis of pneumonia is not recommended in most ventilated patients; it can, however, be useful in some immunocompromised patients 60 .
Treatment
It is widely presumed that treatment outcomes for HAP will be affected by the susceptibilities of the infecting organisms. Treatment should be administered as soon as possible after the diagnosis is considered probable, especially in cases of severe HAP. Early proper antibiotic therapy improves the outcome of HAP with a lower attributable mortality. There is a survival benefit to increasing the percentage of patients who receive antibiotics within the first 4-8 hours 61 . Early appropriate broad-spectrum antimicrobial treatment should be prescribed with sufficient doses to optimize antibiotic efficacy. Therapies which the patients have received within the previous 2 weeks should also be considered, avoiding use of the same antimicrobial class, when possible. Microbiologic results may come too late to influence outcome, and broad-spectrum empirical antimicrobial therapy is often used before microbiologic diagnosis is confirmed 62 . A lower respiratory tract culture needs to be collected before antimicrobial treatment, but collection of cultures should not defer the initiation of therapy in critically ill patients. Either "quantitative" or "semiquantitative" culture data can be used for the treatment of patients with HAP. Quantitative cultures increase specificity of the diagnosis of HAP without negative effects, and the specific quantitative technique should be selected on the basis of 63 . There is no evidence on the conversion of intravenous treatment to oral treatment in the management of HAP, and these decisions must, therefore, be taken on a case-by-case basis according to the clinical response to therapy. Inadequate treatment of HAP should be avoided, because the failure to initiate prompt proper and sufficient treatment has been a factor associated with increased mortality. Inappropriate antimicrobial treatment has also been associated with a lack of clinical improvement in the CPIS, particularly in serial measurements of arterial oxygenation 61 . For patients who are deteriorating quickly (e.g., fever with temperature > 38.3°C, circulating leukocyte count > 10,000 mm 3 , lack of improvement in the chest radiograph, continued purulent sputum) and not responding to initial treatment, it may be necessary to broaden antimicrobial coverage while waiting for the results of cultures and other diagnostic studies. Mismatch between the susceptibility of common causative pathogens, infection with a microbe not covered by the usual empirical treatment, and nosocomial superinfection pneumonia are major causes of obvious antimicrobial failure. No response may also be mimicked by coexistent subsequent extrapulmonary infection, such as intravascular catheter-related infections, urinary, abdominal and skin infections. Appropriate cultures of these sites are taken into account for patients that are non-responsive. In addition to microbiologic diagnostic procedures, other tests such as chest tomography appear to be helpful for selected patients. Chest tomography can reveal other reasons for antibiotics, including pleural effusions, lung abscess, obstruction or bronchiolitis obliterans with organizing pneumonia.
The finding of a rapidly deteriorating radiographic pattern, with a follow-up chest radiograph revealing progression to multilobar involvement, a greater than 50% increase in the size of the infiltrate within 48 hours, development of cavitary disease, or significant pleural effusion, should raise concern 17 . Radiographic improvement usually lags behind clinical parameters, especially in the elderly and in individuals with comorbidities (e.g., COPD) 50 . The radiologic resolution is significantly delayed in patients with a high comorbidity index, bacteremia, multilobar involvement, and Gramnegative microorganisms 63, 64 . Elderly patients with more chronic comorbidities may need a longer duration of therapy until complete resolution of pneumonia-related symptoms is achieved 65 .
Early-onset HAP without risk factors for MDR pathogens is usually caused by antimicrobial-susceptible microbes such as S. pneumoniae, H. influenzae, methicillin-sensitive S. aureus, and antibiotic-sensitive enteric Gram-negative bacilli (E. coli, K. pneumoniae, Enterobacter species, Proteus species, and S. marcescens).
Therapeutic choices of early-onset HAP without risk factors for MDR pathogens include ceftriaxone or levofloxacin, moxifloxacin, ciprofloxacin, ampicillin/sulbactam, or ertapenem. Presently, many strains of S. pneumoniae are penicillin resistant 66 . Despite low and moderate resistance to penicillins and cephalosporins in vitro, clinical results in patients with pneumococcal pneumonia and bacteremia treated with these antibiotics have been satisfactory 66 . The MDR pneumococci are currently sensitive to vancomycin or linezolid, and most remain sensitive to broad-spectrum quinolones. The overuse of fluoroquinolones has also resulted in the emergence of fluoroquinolone-resistant pneumococci 67 . The advantage of combination therapy is most striking in the more severely ill patients 68 .
Klebsiella species are intrinsically resistant to aminopenicillins and can obtain resistance to cephalosporins and aztreonam by the production of extended-spectrum β-lactamases 69 . Plasmid mediated resistance, such as extended-spectrum β-lactamase production, is a more common mechanism for β-lactam resistance in nosocomial isolates, and is increasingly recognized in isolates of K. pneumoniae and E. coli, and Enterobacter species cefepime for this infection is disputed 71 . A reliable option is a carbapenem, which is generally active against these pathogens 72 . Piperacillin-tazobactam against microbes with extended-spectrum β-lactamase is unpredictable and should be used at adequate doses 73 .
A clinical distinction between pneumonia and aspiration pneumonitis may be important for therapeutic management in the elderly. Neither signs and symptoms nor laboratory tests can identify aspiration pneumonia 74 . However, the history of witnessed or suspected aspiration is the only parameter that restricts antimicrobial use in these patients. A reliable selection comprises clindamycin, metronidazole or β-lactamase inhibitor.
MDR organisms are more commonly isolated from patients with severe chronic underlying disorders and patients with late-onset HAP 75 . Having pathogens resistant to the empirical treatment has been independently associated with mortality 62 . An initially appropriate antibiotic regimen could allow reduction of the period of treatment from the traditional 14-21 days to durations as short as 7 days, provided that the etiologic microbe is not P. aeruginosa and that the patient has a good clinical response with resolution of clinical characteristics of infection 63 . Elderly patients with multiple comorbid disorders often recover more slowly. Shortduration treatment may be suboptimal for patients with initial treatment not active against the identified microbes, lung tissue necrosis, bacteremia, S. aureus, and P. aeruginosa. Patients superinfected with P. aeruginosa or Acinetobacter species have a particularly high mortality, around 90% in some series 76 . P. aeruginosa and Acinetobacter are common causes of late-onset pneumonia, especially in the ventilated patient. P. aeruginosa has intrinsic resistance to many antimicrobial agents 77 . Infection caused by P. aeruginosa is associated with a significantly higher incidence of therapeutic failure than those caused by other pathogens 78 .
Treatment should include an antipseudomonal cephalosporin (cefepime, ceftazidime), an antipseudomonal carbapenem (imipenem or meropenem), β-lactam/β-lactamase inhibitor (piperacillin-tazobactam) plus an antipseudomonal fluoroquinolone (ciprofloxacin or levofloxacin), or aminoglycoside (amikacin, gentamicin or tobramycin). Resistant strains of P. aeruginosa with imipenem-type enzymes and other carbapenemases have been reported 79 . Some MDR pathogens of P. aeruginosa are susceptible only to polymyxin B.
Some anecdotal experience has led to a recommendation of aerosolized antibiotics as an adjunct to systemic treatment in patients with highly resistant P. aeruginosa pneumonia 80 . Combination therapy has been continued for less than the full course of therapy, with cessation of the aminoglycoside after 5-7 days if the patient is improving 81 .
Acinetobacter species are generally less virulent than P. aeruginosa, but have, nonetheless, become resistant microbes because of increasing resistance to commonly used antimicrobial agents. Carbapenem resistance has been found in 40% of 3,601 isolates of Acinetobacter baumannii 82 . The most active agents in vitro are the polymyxins, i.e., polymyxin B and polymyxin E (colistin). The nephrotoxicity rates of polymyxin range up to 36%, and neurotoxicity is currently uncommon 83 . An alternative to carbapenem-resistant A. baumannii is combination therapy with other antibiotics, such as rifampin or aminoglycosides, sulbactam, ampicillin-sulbactam, and the polymyxins 84, 85 . Adjunctive treatment with an aerosolized aminoglycoside or polymyxin for carbapenemresistant A. baumannii should be considered, particularly in patients who are not improving with systemic therapy 86 .
Stenotrophomonas maltophilia, which shares with Burkholderia cepacia a tendency to colonize the respiratory tract rather than cause an invasive disorder, is uniformly resistant to carbapenems because of a ubiquitous metallo-β-lactamase. S. maltophilia and B. cepacia are most likely to be susceptible to trimethoprim-sulfamethoxazole, ticarcillin-clavulanate or a fluoroquinolone 87 . B. cepacia is also commonly susceptible to ceftazidime and carbapenems.
S. aureus is ubiquitous in critical care areas. More than 50% of the intensive care unit infections are caused by MRSA 69 Legionella pneumophila occurs sporadically but may be endemic in hospitals with contaminated water systems or cooling units. The incubation period of Legionella infection commonly is 2-10 days; infections that occur more than 10 days after admission are considered to be nosocomial, and infections that develop between 4 and 10 days are considered as possibly nosocomial. The rates of L. pneumophila vary remarkably between hospitals. It occurs more frequently with serogroup 1 when the water supply is colonized 91 . 
General Prophylaxis
Patients at high risk of HAP include those with abdominal aortic aneurysm repair, thoracic surgery or emergency surgery, general anesthesia, age more than 60 years, totally dependent functional status, weight loss of more than 10%, use of steroids for chronic diseases, a recent history of alcohol use, COPD or smoking during the preceding year, impaired sensorium, a history of cerebrovascular disorder with residual neurologic deficit, low (< 8 mg/dL) or high (> 22 mg/dL) blood urea nitrogen level, as well as having received more than four units of blood before operations 96 . An important issue that deserves more recognition regarding the management of HAP in the elderly is prevention. Effective plans include strict infection control, alcoholbased hand disinfection, microbiologic surveillance with timely availability of data on local MDR pathogens, monitoring and early removal of invasive devices, and programs to reduce or alter antimicrobial-prescribing practices.
It is important to preoperatively educate patients at high risk of developing pneumonia on the postoperative use of incentive spirometry. Taking deep breaths and becoming mobile as soon as possible in the postoperative period should also be stressed. Chest physiotherapy may be of value to patients suffering from or at risk of HAP, and it might be appropriate to regard it as a therapeutic option.
Aspiration due to dysphagia is a condition that must be considered, especially in patients with a cerebrovascular accident, confusion, alcoholism, and in bedridden patients. A supine position facilitates aspiration, which may be reduced by semirecumbent positioning 97 . Therefore, patients should be managed in a semirecumbent position, particularly during feeding. The use of oral, endotracheal and orogastric tubes, rather than nasotracheal and nasogastric tubes, can decrease the frequency of nosocomial sinusitis and possibly pneumonia 98, 99 . Parenteral nutrition is associated with a higher risk of intravascular device-associated infections and loss of intestinal villous architecture. Enteral nutrition is favored over parenteral nutrition to reduce the risk of complications 24 . The rate and volume of enteral feeding should be adjusted to avoid gastric distension and to lower the risk of aspiration. A pooled analysis showed no benefit from post-pyloric versus gastric tube feeding in critically ill patients 100 .
Intubation increases the risk of HAP and hence should be avoided whenever possible 19, 101 . To prevent HAP, daily interruption or reduction of sedative/paralytic agents and maintenance of endotracheal cuff pressure at greater than 20 cmH 2 O in patients with intubation is recommended 102 . Repeat insertion of the endotracheal tube and emergency intubation are risk factors for pneumonia 20, 101 . Using noninvasive ventilation and avoiding reintubation after initial extubation may reduce the risk of HAP. Noninvasive positive pressure ventilation is an alternative for patients with acute exacerbations of COPD or acute hypoxemic respiratory failure, and for immunosuppressed patients with pulmonary infiltrates and respiratory failure 103, 104 . A reduced duration of intubation can be gained by the use of weaning protocols to reduce the duration of mechanical ventilatory support and to reduce the risk of HAP 105, 106 .
An inclination to reduce pneumonia with sucralfate and to avoid blood transfusion is necessary 107 .
There is a slightly higher rate of clinically significant 22, 107 . Exposure to blood products is a risk factor for postoperative infection and postoperative pneumonia, and the length of time of blood storage is another factor-modulating risk 108, 109 . Immunosuppressive effects of non-leukocyte-depleted red blood cell units increase the risk of infection. Leukocyte-depleted red blood cell transfusions can reduce HAP in selected patients 110 . We recommend that to prevent HAP, red cell transfusions should be avoided if possible and, if used, should be carried out with fresh red cells 111 .
Prophylaxis for pneumonia in the elderly, with influenza and pneumococcal vaccination, nutritional measures and oral hygiene, is important 34 . Studies in elderly persons have apparently demonstrated that the polysaccharide vaccine prevents an invasive pneumococcal disorder and assures protection for 5-6 years 112 . The pneumococcal vaccine is associated with a decreased antibody response in the elderly 113 . Recent findings have shown that revaccination in elderly people with the polysaccharide vaccine is safe and may give a further immune response 114 . The pneumococcal polysaccharide vaccine is suggested for persons > 65 years of age and particularly for those with selected high-risk coexisting disorders (chronic cardiovascular disease, chronic pulmonary diseases, diabetes mellitus, alcoholism, chronic liver disease, or cerebrospinal fluid leaks, functional or anatomic asplenia, HIV infection, leukemia, lymphoma, Hodgkin disease, multiple myeloma, generalized malignancy, chronic renal failure, nephrotic syndrome, or other conditions related to immunosuppression, such as solid organ transplantation or human stem-cell transplantation, and persons receiving immunosuppressive chemotherapy) 115 . Vaccination may be carried out either at hospital discharge or during outpatient treatment. Nutrition is often overlooked in the elderly with HAP. A low albumin level is a risk factor for developing pneumonia, and a low body mass index is associated with a higher mortality rate. A sufficient diet should be recommended, and the nutritional status of patients should be routinely checked.
Conclusion
Pneumonia in the elderly is a very serious condition that requires swift management. The antibiotic selection should be made based on the most recent guidelines. It is important to recognize the variability of bacteriology from one hospital to another, specific sites within the hospital and from one time period to another, and to use this information to guide the selection of an appropriate antibiotic treatment regimen. Avoiding the overuse of antibiotics by tailoring therapy to the results of lower respiratory tract cultures and shortening the duration of therapy to the minimal effective period is required. The application of preventative strategies aimed at adjustable risk factors should be seriously considered.
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